The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Combined First Trimester Screening
1.2.3 Second Trimester Maternal Serum Screening
1.3 Market by Application
1.3.1 Global Prenatal Cell-Free DNA Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal Cell-Free DNA Screening Market Perspective (2018-2029)
2.2 Prenatal Cell-Free DNA Screening Growth Trends by Region
2.2.1 Global Prenatal Cell-Free DNA Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prenatal Cell-Free DNA Screening Historic Market Size by Region (2018-2023)
2.2.3 Prenatal Cell-Free DNA Screening Forecasted Market Size by Region (2024-2029)
2.3 Prenatal Cell-Free DNA Screening Market Dynamics
2.3.1 Prenatal Cell-Free DNA Screening Industry Trends
2.3.2 Prenatal Cell-Free DNA Screening Market Drivers
2.3.3 Prenatal Cell-Free DNA Screening Market Challenges
2.3.4 Prenatal Cell-Free DNA Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal Cell-Free DNA Screening Players by Revenue
3.1.1 Global Top Prenatal Cell-Free DNA Screening Players by Revenue (2018-2023)
3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Players (2018-2023)
3.2 Global Prenatal Cell-Free DNA Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prenatal Cell-Free DNA Screening Revenue
3.4 Global Prenatal Cell-Free DNA Screening Market Concentration Ratio
3.4.1 Global Prenatal Cell-Free DNA Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal Cell-Free DNA Screening Revenue in 2022
3.5 Prenatal Cell-Free DNA Screening Key Players Head office and Area Served
3.6 Key Players Prenatal Cell-Free DNA Screening Product Solution and Service
3.7 Date of Enter into Prenatal Cell-Free DNA Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal Cell-Free DNA Screening Breakdown Data by Type
4.1 Global Prenatal Cell-Free DNA Screening Historic Market Size by Type (2018-2023)
4.2 Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Type (2024-2029)
5 Prenatal Cell-Free DNA Screening Breakdown Data by Application
5.1 Global Prenatal Cell-Free DNA Screening Historic Market Size by Application (2018-2023)
5.2 Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prenatal Cell-Free DNA Screening Market Size (2018-2029)
6.2 North America Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prenatal Cell-Free DNA Screening Market Size by Country (2018-2023)
6.4 North America Prenatal Cell-Free DNA Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal Cell-Free DNA Screening Market Size (2018-2029)
7.2 Europe Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2018-2023)
7.4 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Cell-Free DNA Screening Market Size (2018-2029)
8.2 Asia-Pacific Prenatal Cell-Free DNA Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prenatal Cell-Free DNA Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Prenatal Cell-Free DNA Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal Cell-Free DNA Screening Market Size (2018-2029)
9.2 Latin America Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2018-2023)
9.4 Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size (2018-2029)
10.2 Middle East & Africa Prenatal Cell-Free DNA Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Yourgene Health
11.1.1 Yourgene Health Company Detail
11.1.2 Yourgene Health Business Overview
11.1.3 Yourgene Health Prenatal Cell-Free DNA Screening Introduction
11.1.4 Yourgene Health Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.1.5 Yourgene Health Recent Development
11.2 Illumina Inc
11.2.1 Illumina Inc Company Detail
11.2.2 Illumina Inc Business Overview
11.2.3 Illumina Inc Prenatal Cell-Free DNA Screening Introduction
11.2.4 Illumina Inc Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.2.5 Illumina Inc Recent Development
11.3 Agilent Technologies Inc
11.3.1 Agilent Technologies Inc Company Detail
11.3.2 Agilent Technologies Inc Business Overview
11.3.3 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Introduction
11.3.4 Agilent Technologies Inc Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.3.5 Agilent Technologies Inc Recent Development
11.4 Thermo Fisher Scientific Inc
11.4.1 Thermo Fisher Scientific Inc Company Detail
11.4.2 Thermo Fisher Scientific Inc Business Overview
11.4.3 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Introduction
11.4.4 Thermo Fisher Scientific Inc Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.4.5 Thermo Fisher Scientific Inc Recent Development
11.5 Hoffmann-La Roche Ltd
11.5.1 Hoffmann-La Roche Ltd Company Detail
11.5.2 Hoffmann-La Roche Ltd Business Overview
11.5.3 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Introduction
11.5.4 Hoffmann-La Roche Ltd Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.5.5 Hoffmann-La Roche Ltd Recent Development
11.6 Laboratory Corporation of America Holdings
11.6.1 Laboratory Corporation of America Holdings Company Detail
11.6.2 Laboratory Corporation of America Holdings Business Overview
11.6.3 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Introduction
11.6.4 Laboratory Corporation of America Holdings Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.6.5 Laboratory Corporation of America Holdings Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Prenatal Cell-Free DNA Screening Introduction
11.7.4 GE Healthcare Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 PerkinElmer Inc
11.8.1 PerkinElmer Inc Company Detail
11.8.2 PerkinElmer Inc Business Overview
11.8.3 PerkinElmer Inc Prenatal Cell-Free DNA Screening Introduction
11.8.4 PerkinElmer Inc Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.8.5 PerkinElmer Inc Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Prenatal Cell-Free DNA Screening Introduction
11.9.4 BGI Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.9.5 BGI Recent Development
11.10 Natera Inc
11.10.1 Natera Inc Company Detail
11.10.2 Natera Inc Business Overview
11.10.3 Natera Inc Prenatal Cell-Free DNA Screening Introduction
11.10.4 Natera Inc Revenue in Prenatal Cell-Free DNA Screening Business (2018-2023)
11.10.5 Natera Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details